Cargando…
Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection
Autores principales: | Sacher, Frederic, Fauchier, Laurent, Boveda, Serge, de Chillou, Christian, Defaye, Pascal, Deharo, Jean Claude, Gandjbakhch, Estelle, Probst, Vincent, Cohen, Ariel, Leclercq, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180362/ https://www.ncbi.nlm.nih.gov/pubmed/32354666 http://dx.doi.org/10.1016/j.acvd.2020.04.003 |
Ejemplares similares
-
Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()
por: Galand, Vincent, et al.
Publicado: (2021) -
How is Contact Force implemented in routine clinical practice? Results from a French National and Monaco Survey
por: Bun, Sok‐Sithikun, et al.
Publicado: (2019) -
Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women—Data From a Multicenter French Registry
por: Providência, Rui, et al.
Publicado: (2016) -
Cardiac pacing and lead devices management: 25 years of research at EP Europace journal
por: Defaye, Pascal, et al.
Publicado: (2023) -
Role of medical reaction in management of inappropriate ventricular arrhythmia diagnosis: the inappropriate Therapy and HOme monitoRiNg (THORN) registry
por: Perrin, Tilman, et al.
Publicado: (2019)